# Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision

> **NCT01053858** · NA · COMPLETED · sponsor: **Hallym University Medical Center** · enrollment: 38 (actual)

## Conditions studied

- Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity

## Interventions

- **PROCEDURE:** intravitreal injection

## Key facts

- **NCT ID:** NCT01053858
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2010-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2010-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053858, "Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01053858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*